ACTUATE THERAPEUTICS, INC. (ACTU)

Director SCHMITT DANIEL M 🟡 adjusted position in 120.5K shares (1 derivative) of ACTUATE THERAPEUTICS, INC. (ACTU) at $1.01 Transaction Date: Aug 14, 2026 | Filing ID: 006493

Register to leave comments

  • News bot Aug. 14, 2026, 9 p.m.

    🔍 SCHMITT DANIEL M (Director)

    Company: ACTUATE THERAPEUTICS, INC. (ACTU)

    Report Date: 2026-08-14

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 1
    • Holdings reported: 4
    • Total shares acquired: 272,056
    • Total shares sold: 392,577
    • Total shares held: 630,740

    Detailed Transactions and Holdings:

    • Acquired 272,056 shares of Common Stock (Direct)
      Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 422,237.00 | transaction_form_type: 4 | Footnotes: F3, F4, F3
    • Sold 120,521 shares of Common Stock at $1.01 per share (Direct)
      Date: 2026-08-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 301,716.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-14 | Code: H | nature_of_ownership: By The Schmitt Family Irrevocable Trust, dated December 31, 2019 | shares_owned_after: 564,071.00 | Footnotes: F6
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-14 | Code: H | nature_of_ownership: By The Andrew Schmitt Irrevocable Trust, dated December 31, 2019 | shares_owned_after: 22,223.00 | Footnotes: F7
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-14 | Code: H | nature_of_ownership: By The Anna Schmitt Irrevocable Trust, dated December 31, 2019 | shares_owned_after: 22,223.00 | Footnotes: F8
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-14 | Code: H | nature_of_ownership: By The Edward Schmitt Irrevocable Trust, dated December 31, 2019 | shares_owned_after: 22,223.00 | Footnotes: F9
    • Sold 272,056 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F4, F5, F5

    Footnotes:

    • F1: Represents 120,521 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units ("RSUs").
    • F2: Represents the closing price of Issuer's common stock on August 14, 2026.
    • F3: Represents the issuance of 272,056 shares of common stock from the vesting and settlement of 272,056 RSUs, which number excludes the withholding of 120,521 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1).
    • F4: Each restricted stock unit represents a contingent right to receive one share of common stock.
    • F5: 544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vested on August 14, 2026.
    • F6: Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee (the "Schmitt Family Trust").
    • F7: Represents shares held by The Andrew Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
    • F8: Represents shares held by The Anna Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
    • F9: Represents shares held by The Edward Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.